RESUMEN
OBJECTIVE: To synthesize the methodologies of studies that evaluate the impacts of heat exposure on morbidity and mortality. METHODS: Embase, MEDLINE, Web of Science, and Scopus were searched from date of inception until 1 March 2023 for English language literature on heat exposure and health outcomes. Records were collated, deduplicated and screened, and full texts were reviewed for inclusion and data abstraction. Eligibility for inclusion was determined as any article with climate-related heat exposure and an associated morbidity/mortality outcome. RESULTS: Of 13,136 records initially identified, 237 articles were selected for analysis. The scope of research represented 43 countries, with most studies conducted in China (62), the USA (44), and Australia (16). Across all studies, there were 141 unique climate data sources, no standard threshold for extreme heat, and 200 unique health outcome data sources. The distributed lag non-linear model (DLNM) was the most common analytic method (48.1% of studies) and had high usage rates in China (68.9%) and the USA (31.8%); Australia frequently used conditional logistic regression (50%). Conditional logistic regression was most prevalent in case-control studies (5 of 8 studies, 62.5%) and in case-crossover studies (29 of 70, 41.4%). DLNMs were most common in time series studies (64 of 111, 57.7%) and ecological studies (13 of 20, 65.0%). CONCLUSIONS: This review underscores the heterogeneity of methods in heat impact studies across diverse settings and provides a resource for future researchers. Underrepresentation of certain countries, health outcomes, and limited data access were identified as potential barriers.
RESUMEN
Objectives: Provide a robust framework to provide a safe environment for return to training and competition of the US national soccer teams following domestic and international travel. Methods: US Soccer COVID-19 working group created a return to play manual for its national teams, prescribing discrete phases to return to training and competition. This was underpinned by strict health and safety and travel protocols for specific venues and persons. This was complemented by an aggressive testing cadence and isolation policies for delegations (players, internal and external support staff). Between September 2020 and April 2021, there were nine events for males and females at the youth, senior and Paralympic level, with international opponents hosted domestically. Results: In total, 6590 point of care (POC) (n=1810) and PCR (n=4780) tests combined were run. Overall positivity rate for players and staff in male events of 0.10% (n=2) and 0.00% (n=0) for females were recorded. Staff positivity rate was 0.14% overall, and external vendors 0.10%. Total POC and PCR positives in male events (n=2) occurred either the day of arrival or the following day. Conclusion: The implementation of strictly adhered to protocols and testing cadences yielded low positivity rates within team delegations. By comparison, initial league-wide COVID-19 testing in mid-2020 in other sports reported league-wide positivity rates of 2.9% (National Football League), 2.7% (Major League Soccer) and 5.3% (National Basketball Association). The English Premier League reported an increase in positivity rate in early 2021 from 1.22% to 1.74%.With the implementation of regimented protocols and stringent testing, it is possible to hold elite-level international sporting competitions involving long-haul travel while ensuring continued safety during a global pandemic.
RESUMEN
BACKGROUND: In the 2.8 years of the Diabetes Prevention Program (DPP) randomised clinical trial, diabetes incidence in high-risk adults was reduced by 58% with intensive lifestyle intervention and by 31% with metformin, compared with placebo. We investigated the persistence of these effects in the long term. METHODS: All active DPP participants were eligible for continued follow-up. 2766 of 3150 (88%) enrolled for a median additional follow-up of 5.7 years (IQR 5.5-5.8). 910 participants were from the lifestyle, 924 from the metformin, and 932 were from the original placebo groups. On the basis of the benefits from the intensive lifestyle intervention in the DPP, all three groups were offered group-implemented lifestyle intervention. Metformin treatment was continued in the original metformin group (850 mg twice daily as tolerated), with participants unmasked to assignment, and the original lifestyle intervention group was offered additional lifestyle support. The primary outcome was development of diabetes according to American Diabetes Association criteria. Analysis was by intention-to-treat. This study is registered with ClinicalTrials.gov, number NCT00038727. FINDINGS: During the 10.0-year (IQR 9.0-10.5) follow-up since randomisation to DPP, the original lifestyle group lost, then partly regained weight. The modest weight loss with metformin was maintained. Diabetes incidence rates during the DPP were 4.8 cases per 100 person-years (95% CI 4.1-5.7) in the intensive lifestyle intervention group, 7.8 (6.8-8.8) in the metformin group, and 11.0 (9.8-12.3) in the placebo group. Diabetes incidence rates in this follow-up study were similar between treatment groups: 5.9 per 100 person-years (5.1-6.8) for lifestyle, 4.9 (4.2-5.7) for metformin, and 5.6 (4.8-6.5) for placebo. Diabetes incidence in the 10 years since DPP randomisation was reduced by 34% (24-42) in the lifestyle group and 18% (7-28) in the metformin group compared with placebo. INTERPRETATION: During follow-up after DPP, incidences in the former placebo and metformin groups fell to equal those in the former lifestyle group, but the cumulative incidence of diabetes remained lowest in the lifestyle group. Prevention or delay of diabetes with lifestyle intervention or metformin can persist for at least 10 years. FUNDING: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).